Introduction {#S1}
============

Energy drinks (ED) are non-alcoholic beverages marketed to improve energy, stamina, athletic performance, and concentration. Categorized as "functional beverages" alongside sports drinks and nutraceuticals, the ED industry has grown dramatically in the past 20 years, reaching over \$9.7 billion in United States (U.S.) sales in 2015, with two brands accounting for nearly 85% of the market ([@B1]). The target consumer market for ED is adolescents and young adults ([@B1]), with one study finding that 51% of college students report consuming at least one ED each month ([@B2]). While annual sales of ED remain dwarfed by those of soft drinks and coffee, there are concerns that lax regulation of marketing and ingredient labeling is spurring a trend of increased consumption. Since their introduction to the U.S. market in 1997, there has been a significant increasing trend in ED consumption among children, adolescents, and adults, although the proportion of calories attributable to ED is still marginal compared to other sugar-sweetened beverages (SSBs) such as soda and fruit juice ([@B3], [@B4]). The rising prevalence of ED consumption is particularly problematic given the emerging evidence of association with negative health consequences such as risk-seeking behaviors, adverse cardiovascular effects, and metabolic, renal, or dental conditions ([@B5], [@B6]). Updating and integrating the findings of some previous reviews ([@B7], [@B8]), this mini-review summarizes the current scientific evidence on ED health effects, presents relevant public health challenges, and proposes recommendations to amend these issues.

Constituents and Ingredients {#S2}
============================

Despite the vast array of ED available in the U.S., most ED contain similar ingredients including water, sugar, caffeine, non-nutritive stimulants (e.g., guarana, ginseng, yerba mate, taurine, [l]{.smallcaps}-carnitine, [d]{.smallcaps}-glucuronolactone, and inositol) and certain vitamins and minerals (e.g., B vitamins) ([@B1], [@B9]). The caffeine content in ED ranges widely from 47 to 80 mg per 8 oz to as high as 207 mg per 2 oz and comes from a number of ingredient sources ([@B10]). While moderate caffeine intake (up to 400 mg/day) is generally considered safe and even beneficial for health among adults ([@B11]), there has not been extensive research conducted on children and adolescents to determine if any tolerable level exists ([@B12]). ED also contain large amounts of high fructose-corn syrup, sucrose, or artificial sweeteners. The amount of sugar contained in one can (500 mL or 16.9 oz) of an ED is typically about 54 g ([@B13]). Many institutions, including the World Health Organization, have recommended reducing sugar intake due to the strong evidence linking consumption of added sugar to poor health ([@B14]).

Reports on other constituents of ED are relatively limited. Guarana is a plant extract native to South America which contains a significant amount of caffeine, with 1 g of guarana equivalent to 40 mg of caffeine ([@B15]). Due to this particularly high caffeine content, guarana is often included as an ingredient in ED for its stimulatory effect ([@B1], [@B16]). Ginseng is an herbal supplement that has been used for thousands of years in East Asia and has reported health benefits including vasorelaxation, antioxidation, anti-inflammation, and anticancer ([@B17], [@B18]). Like guarana, yerba mate has a high caffeine concentration (78 mg caffeine per cup) ([@B1]) and is additionally thought to have benefits in the form of antioxidant capacity, weight management, and cancer prevention ([@B19]). Taurine has been reported to have anti-inflammatory actions and has been suggested in the treatment of epilepsy, heart failure, cystic fibrosis, and diabetes ([@B20]). B vitamins refer to a group of eight water soluble vitamins which generally play an important role in cell functioning, with vitamin B2 (riboflavin), B3 (niacin), B6 (pyridoxine, pyridoxal, and pyridoxamine), and B12 being the most common B vitamins added to ED ([@B1]). Despite the importance of B vitamins as coenzymes in various metabolic processes, most individuals in the U.S. already meet the recommended daily amount and hence the additional B vitamins added to ED are often excreted from the body with urine, failing to impart any additional health effect ([@B1]). The literature on the content and function of other additives such as [l]{.smallcaps}-carnitine, [d]{.smallcaps}-glucuronolactone, and inositol is limited, with a few studies suggesting moderate benefits ([@B18]).

Health Effects of ED {#S3}
====================

Improved Cognitive and Physical Performance {#S3-1}
-------------------------------------------

Some studies support the temporary health benefits of ED in improving mental and physical stamina among both adults and adolescents. Several randomized controlled trials among adults have shown an association between components of ED and improved subjective alertness ([@B21]), as well as restoration of fatigue ([@B22]). Due to its similar structure to adenosine, caffeine can inhibit sleep through its competitive binding to the adenosine receptor ([@B23]). Studies have also shown the effect of ED on improved physical activity performance in young-adult athletes ([@B24]--[@B27]). A recent meta-analysis of acute-effect studies conducted among adults found that ED consumption improved muscle strength and endurance, performance on endurance exercise tests, jumping, and sport-specific actions ([@B28]).

In contrast, the vast majority of evidence suggests negative health effects of both short- and long-term ED consumption (Table [1](#T1){ref-type="table"}), with most literature proposing these health disadvantages are attributable to high levels of caffeine and sugar while highlighting that more research is needed on the effects of other ED constituents.

###### 

Summary of negative health effects of energy drinks (ED).

  Category of health effects                                                     Major effects observed
  ------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Risk-seeking behaviors                                                         Substance abuse: alcohol, cigarettes, marijuana, amphetamines ([@B32], [@B35])Aggressive behavior: fighting, bullying, truancy ([@B35])
  Mental health effects                                                          Stress, anxiety, depressive symptoms, suicidal ideation, plan or attempt ([@B33], [@B36], [@B37])Low academic achievement ([@B35])
  Adverse cardiovascular effects                                                 Increased systolic and diastolic blood pressure ([@B39], [@B41])Increased heart rate ([@B39])
  Adverse metabolic, dental, or renal effects[^a^](#tfn1){ref-type="table-fn"}   Overweight/obesity risk ([@B44], [@B47]--[@B49])Risk of metabolic/type 2 diabetes ([@B48])Dental decay ([@B51], [@B52])Renal microvascular damage and accelerated progression of chronic kidney disease ([@B53]--[@B55])
  Other health effects                                                           Sleep dissatisfaction, tiredness/fatigue, late bedtime, headaches, stomachaches and irritation ([@B35], [@B56]--[@B59])

*^a^The evidence for adverse metabolic and dental effects comes from studies on sugar-sweetened beverages in general; ED are often classified as such as they contain added sugar*.

Risk-Seeking Behaviors and Mental Health Effects {#S3-2}
------------------------------------------------

Several studies report a consistent association between ED consumption and substance abuse, although the evidence base consists primarily of cross-sectional studies, which does not allow for establishing directionality of the association ([@B29]--[@B34]). For example, in a nationally representative sample of U.S. middle- and high-school students, significant associations were found between ED frequency and 30-day frequency of use of alcohol, cigarettes, marijuana, or amphetamines ([@B32]). This echoes cross-sectional results among adolescent regular consumers (\>1 ED/week) in Europe who were more likely to smoke and drink alcohol compared to non-consumers ([@B35]). Some studies have additionally found evidence for an association between ED consumption and mental health, including stress, anxiety, depressive symptoms, and suicidal ideation, plan or attempt ([@B33], [@B36], [@B37]). For example, teenagers in Canada who reported ED consumption more than once a month were nearly three times more likely to report elevated depressive symptoms compared to those who did not report ED consumption ([@B33]). A review of ED consumption and mental health among adolescents and adults supported a positive association between chronic ED use and undesirable mental health effects, including stress, anxiety, and depression ([@B37]). The authors postulate that this association may be moderated by dysregulated sleep, such that consuming heavily caffeinated ED may result in sleep loss which in turn may contribute to poor functioning and mental health.

Adverse Cardiovascular Effects {#S3-3}
------------------------------

Numerous studies have explored the short-term effects of ED on the cardiovascular system, primarily with respect to caffeine and sugar ([@B38]--[@B40]). For example, a recent randomized crossover study on healthy subjects found that consumption of 355 mL of an ED resulted in increased systolic and diastolic blood pressure, heart rate, and cardiac output ([@B39]). A 2016 meta-analysis of 15 studies similarly reported that acute ED consumption resulted in increased systolic and diastolic blood pressure across the pooled results ([@B41]). Although the meta-analysis did not find evidence for increased heart rate, the researchers noted the need for well-designed studies before any conclusions can be made.

Caffeine toxicity is believed to occur above 400 mg/day for adults, 100 mg/day for adolescents (12--18 years), and 2.5 mg/kg of body weight for children (\<12 years), with serious symptoms often related to cardiovascular effects ([@B42]). In the 1-year period between October 2010 and September 2011, the U.S. National Poison Data System received 4,854 ED-related calls, including major adverse events such as seizure, dysrhythmia, and tachypnea ([@B42]). Data from Australian poisons centers confirm these major symptoms of recreational or accidental ED intake among children and adolescents, in addition to palpitations, agitation, and tremor ([@B43]). Given that these data relies on self-reported signs and symptoms and most consumers may not readily identify ED as a poison, it is likely that ED-related toxicity reports are underestimated. It is believed that the potential for caffeine toxicity from ED is greater than other caffeine sources such as coffee or tea due to inadequate labeling and greater volume of consumption driven by heavy advertising promoting "more is better," especially among children and youth ([@B5]).

Adverse Metabolic, Dental, or Renal Effects {#S3-4}
-------------------------------------------

Sugar-sweetened beverages, which refer to beverages with added sugar such as soda, fruit juice, and many ED, are consistently associated with long-term negative health effects particularly among children and adolescents ([@B44]--[@B46]). Primarily, SSBs have been linked to overweight/obesity risk and metabolic conditions such as type 2 diabetes ([@B44], [@B47]--[@B49]), potentially through the low satiety of SSBs and consumers not sufficiently reducing total energy intake to account for the additional calories of SSBs ([@B50]). In addition, consumption of SSBs increases blood glucose and insulin levels, contributing to a high glycemic load which is associated with glucose intolerance and insulin resistance ([@B48]). SSBs are also associated with a high prevalence of dental caries, wherein bacteria in the mouth utilize the sugars from SSBs and produce acid that decays the teeth ([@B51], [@B52]). Finally, renal diseases, specifically renal microvascular damage ([@B53]) and accelerated progression of chronic kidney disease, have been shown to be induced by fructose in SSBs in animal-based models ([@B54], [@B55]).

Other Health Effects {#S3-5}
--------------------

Energy drinks' consumption is also associated with other commonly reported health problems such as sleep dissatisfaction, tiredness/fatigue, late bedtime, headaches, and stomachaches and irritation ([@B35], [@B56]--[@B59]). It is likely that many of these general health complaints are attributable to caffeine or sugar content, but additional research needs to be conducted to confirm this, as well as to assess the potential effect of other constituents. In a cross-sectional study conducted in Finland, consumers of ED had a 4.6 (95% CI: 2.8, 7.7) times greater odds of headaches, 3.6 (95% CI: 2.2, 5.8) times greater odds of sleeping problems, and 4.1 (95% CI: 2.7, 6.1) times greater odds of having an irritable mood compared to non-consumers ([@B57]).

Limitations of the Existing Literature {#S3-6}
--------------------------------------

The literature generally suggests that the negative health effects of ED outweigh the beneficial effects. However, there are considerable limitations to the existing literature. First, most studies on ED are cross-sectional, limiting the ability to establish temporal relationships and support causality. In addition, many articles used small homogenous populations, often consisting of healthy, young to middle-aged adults, thus limiting generalizability to the U.S. population. Finally, studies specifically examining the effects of other ED constituents are lacking and thus there is limited knowledge on the potential mechanisms beyond those of caffeine and sugar, for which most of the literature exist.

Relevant Public Health Challenges {#S4}
=================================

Energy Drink Marketing {#S4-1}
----------------------

Since 2004, aggressive advertising by ED companies has led to substantial market growth, with a more than 240% increase in sales in the U.S. and worldwide. ED are now available in more than 140 countries ([@B8]) and are on track to become a \$21 billion industry in the U.S. by 2017 ([@B60]).

Energy drinks' marketing strategies pose a significant public health threat in the U.S. due to the size of their target adolescent market and the marketing strategies they employ. ED face heavy competition for market share with SSB corporations that dwarf them in size, customer base, distribution capability, and ability to invest in advertising ([@B61]). To compete, ED companies target the approximately 33.5 million 12- to 19-year olds in the U.S. ([@B62]). The public health implications of targeting adolescents are not trivial: adolescents lack maturity in key areas of the brain, are biologically predisposed to have poor impulse control, and are more likely to engage in risk-taking behavior ([@B63]). This not only makes them more likely to consume the product on a regular basis but also makes them more vulnerable to identifying and potentially engaging in sexual and risk-taking behaviors depicted in ED marketing.

Adolescents' vulnerability to the marketing tactics of ED companies is particularly serious given that ED are now omnipresent across multiple vending channels with price points widely affordable to all strata of the population. There are few signs that the scale and targeting of ED marketing will change in the near future. A 2014 study on ED marketing conducted by the offices of several U.S. Senators found that of the sixteen companies they approached, only four agreed to avoid marketing their products to children ([@B64]).

Lack of Regulation and Taxation {#S4-2}
-------------------------------

Overall, there is a significant lack of ED regulation in the U.S. ([@B65]). While the Food and Drug Administration (FDA) enforces a caffeine limit of 71 mg per 12 fluid ounces for soda, ED manufacturers can avoid this by classifying their product as a "supplement," regulated under the 1994 Dietary Supplement and Education Act and not subject to any caffeine limits ([@B1], [@B8]). That said, many ED companies are moving to marketing their products as beverages to address public concerns that their products are circumventing labeling requirements and also to enable ED to be available to participants of the Supplemental Nutrition Assistance Program, a U.S. nutrition assistance program providing low-income individuals with financial support to purchase food and beverages.

In 2014, the American Beverage Association published the "Guidance for the Responsible Labeling and Marketing of Energy Drinks," which allowed ED companies to voluntarily commit to a number of industry goals ([@B66]). The companies committed to report total quantities of caffeine from all sources, restrict marketing to children, and voluntarily report adverse events to the FDA. However, an assessment report found that compliance to this commitment was staggeringly low ([@B64]), with 8 of 12 companies still marketing to children and 4 of 10 companies not willing to report adverse events voluntarily. Other countries facing similar challenge to the U.S. have implemented various approaches to regulate ED. For example, Australia and New Zealand created a unique regulatory category for ED called "formulated caffeine beverages," and set the upper limit of caffeine from any source to be 320 mg/L ([@B65]).

In addition to regulation, some countries have implemented taxation policies as a deterrent to ED consumption. Mexico currently taxes all non-alcoholic beverages with added sugar, including ED, at one-peso-per-liter, with recent assessments reporting that purchases of taxed beverages have decreased by an average of 6% since implementation in January 2014 ([@B67]). Similarly successful initiatives have been emerging in some U.S. cities ([@B68]).

Alcohol and Energy Drink Mixing {#S4-3}
-------------------------------

In addition to being consumed alone, ED are frequently mixed with alcohol, with one study in the European Union finding that 71% of young adults report consuming ED with alcohol ([@B69]). This is problematic because individuals who drink alcohol-mixed ED consume more alcohol than if they were drinking alcohol alone ([@B70], [@B71]). Researchers attribute this to the fact that consumption of ED masks the signs of alcohol inebriation, enabling an individual to believe they can still safely consume more alcohol, leading to "awake drunkenness" ([@B72]). As a result of this increased alcohol consumption, those who drink alcohol-mixed ED are more likely to experience severe dehydration and alcohol poisoning ([@B73]). This negative health trend is particularly concerning as it disproportionately affects underage individuals and has been linked to binge drinking, alcohol-dependence behaviors ([@B70]) and drunk driving ([@B74]).

Recommendations and Future Directions {#S5}
=====================================

Public health and policy action must be taken to mitigate the negative health effects and public health challenges associated with ED. First, the FDA should consider regulation of ED as a separate category, requiring clear labeling of total caffeine and sugar content in reference to daily recommended amounts, and enforcing an upper limit for caffeine based on current evidence. Additional consideration should be given to taxing ED and/or restricting the sale of ED to children and adolescents. Marketing strategies should be also regulated to minimize the promotion of ED among adolescent and young adults. Because marketing is largely aimed at this segment of the population, exposure to ED products could be reduced considerably. In parallel, further research should continue to improve the quality of the evidence on the health effects of ED with particular attention to observational studies with longer follow-up, more heterogeneous populations, and the effects of other ED constituents. Finally, adolescents and their parents should be educated on the adverse nutritional content and subsequent health effects of ED so that they can make informed decisions about consumption.

Despite some limited beneficial short-term effects, ED should be considered a significant public health problem that warrants attention. The growing evidence base demonstrating associations between ED consumption and negative health effects and public health challenges point to the need for close surveillance and assessment of this issue by researchers and policy makers.
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